Literature DB >> 11181125

Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care.

L R Peterson1, J D Hamilton, E J Baron, L S Tompkins, J M Miller, C M Wilfert, F C Tenover, R B Thomson.   

Abstract

Modern medicine has led to dramatic changes in infectious diseases practice. Vaccination and antibiotic therapy have benefited millions of persons. However, constrained resources now threaten our ability to adequately manage threats of infectious diseases by placing clinical microbiology services and expertise distant from the patient and their infectious diseases physician. Continuing in such a direction threatens quality of laboratory results, timeliness of diagnosis, appropriateness of treatment, effective communication, reduction of health care-associated infections, advances in infectious diseases practice, and training of future practitioners. Microbiology laboratories are the first lines of defense for detection of new antibiotic resistance, outbreaks of foodborne infection, and a possible bioterrorism event. Maintaining high-quality clinical microbiology laboratories on the site of the institution that they serve is the current best approach for managing today's problems of emerging infectious diseases and antimicrobial agent resistance by providing good patient care outcomes that actually save money.

Entities:  

Mesh:

Year:  2001        PMID: 11181125     DOI: 10.1086/318725

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  31 in total

Review 1.  Hunting health care-associated infections from the clinical microbiology laboratory: passive, active, and virtual surveillance.

Authors:  Lance R Peterson; Stephen E Brossette
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

Review 2.  Response of the clinical microbiology laboratory to emerging (new) and reemerging infectious diseases.

Authors:  Franklin R Cockerill; Thomas F Smith
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

3.  Accuracy and appropriateness of antimicrobial susceptibility test reporting for bacteria isolated from blood cultures.

Authors:  Daniel J Diekema; Kathleen Lee; Patti Raney; Loreen A Herwaldt; Gary V Doern; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

4.  Survival of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus spp. for an extended period of transport.

Authors:  Gwen L Robinson; Anthony D Harris; Daniel J Morgan; Lisa Pineles; Beverly M Belton; J Kristie Johnson
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

5.  The clinical microbiology laboratory director in the United States hospital setting.

Authors:  Richard B Thomson; Michael L Wilson; Melvin P Weinstein
Journal:  J Clin Microbiol       Date:  2010-08-25       Impact factor: 5.948

6.  Comparison between nasal swabs and nasopharyngeal aspirates for, and effect of time in transit on, isolation of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, and Moraxella catarrhalis.

Authors:  Kylie S Carville; Jacinta M Bowman; Deborah Lehmann; Thomas V Riley
Journal:  J Clin Microbiol       Date:  2006-11-01       Impact factor: 5.948

7.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

8.  Septicemic plague in a community hospital in California.

Authors:  David A Margolis; Joseph Burns; Sharon L Reed; Michele M Ginsberg; Terrence C O'Grady; Joseph M Vinetz
Journal:  Am J Trop Med Hyg       Date:  2008-06       Impact factor: 2.345

9.  Laboratory automation reduces time to report of positive blood cultures and improves management of patients with bloodstream infection.

Authors:  Giuseppe Vittorio De Socio; Francesco Di Donato; Riccardo Paggi; Chiara Gabrielli; Alessandra Belati; Giuseppe Rizza; Martina Savoia; Antonella Repetto; Elio Cenci; Antonella Mencacci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-14       Impact factor: 3.267

10.  Biographical Feature: Ellen Jo Baron, M.S., Ph.D.

Authors:  Betty A Forbes
Journal:  J Clin Microbiol       Date:  2018-10-25       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.